telmisartan has been researched along with Brain Inflammation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asraf, K; Cohen, H; Fleisher-Berkovich, S; Torika, N | 1 |
| Garrido-Gil, P; Kulisevsky, J; Labandeira-Garcia, JL; Lanciego, JL; Pedrosa, MA; Rodriguez-Perez, AI; Sucunza, D | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
| He, L; Huang, Z; Jiang, Z; Li, J; Liao, H; Pang, T; Saavedra, JM; Wang, Y; Xu, Y; Zhang, L | 1 |
| Garrido-Gil, P; Guerra, MJ; Joglar, B; Labandeira-Garcia, JL; Rodriguez-Perez, AI | 1 |
5 other study(ies) available for telmisartan and Brain Inflammation
| Article | Year |
|---|---|
Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Polarity; Cerebral Cortex; Disease Models, Animal; Encephalitis; Female; Gliosis; Humans; Male; Mice; Mice, Transgenic; Microglia; Spatial Processing; Telmisartan | 2017 |
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.
Topics: alpha-Synuclein; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcium-Binding Proteins; Cell Death; Cytokines; Dependovirus; Disease Models, Animal; Dopaminergic Neurons; Encephalitis; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Humans; Male; Microfilament Proteins; Microscopy, Confocal; Mutation; Rats; Rats, Sprague-Dawley; Synapsins; Telmisartan; Tetrazoles; Transduction, Genetic; Tyrosine 3-Monooxygenase | 2018 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |
Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKβ-dependent AMPK activation.
Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Polarity; Cerebral Cortex; Encephalitis; HeLa Cells; Humans; Illness Behavior; Lipopolysaccharides; Mice; Microglia; Signal Transduction; Telmisartan | 2015 |
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Brain; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Encephalitis; Gene Expression Regulation; Lectins; Leukocyte Common Antigens; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; MPTP Poisoning; PPAR gamma; Receptor, Angiotensin, Type 1; Telmisartan; Tyrosine 3-Monooxygenase | 2012 |